These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 1355542

  • 1. Decarboxylation of L-dopa in the rat isolated vascularly perfused small intestine: contribution to systemic elimination and dose-dependent first pass effect.
    de Vries MH, Hamelijnck MA, Hofman GA, Koster AS, Noordhoek J.
    J Pharm Pharmacol; 1992 Apr; 44(4):311-4. PubMed ID: 1355542
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic modelling of the effect of activated charcoal on the intestinal secretion of theophylline, using the isolated vascularly perfused rat small intestine.
    de Vries MH, Rademaker CM, Geerlings C, Van Dijk A, Noordhoek J.
    J Pharm Pharmacol; 1989 Aug; 41(8):528-33. PubMed ID: 2571696
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Age dependence in capacity-limited jejunal decarboxylation of levodopa in rats.
    Iwamoto K, Watanabe J, Atsumi F.
    Biochem Pharmacol; 1987 Jul 01; 36(13):2151-5. PubMed ID: 3606633
    [Abstract] [Full Text] [Related]

  • 10. Intestinal decarboxylation of orally administered L-dopa. Influence of pharmacological preparations, dose magnitude, dose sequence and food intake.
    Andersson I, Granerus AK, Jagenburg R, Svanborg A.
    Acta Med Scand; 1975 Nov 01; 198(5):415-20. PubMed ID: 1199816
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson's disease.
    Camargo SM, Vuille-dit-Bille RN, Mariotta L, Ramadan T, Huggel K, Singer D, Götze O, Verrey F.
    J Pharmacol Exp Ther; 2014 Oct 01; 351(1):114-23. PubMed ID: 25073474
    [Abstract] [Full Text] [Related]

  • 14. Increases in intestinal glucose absorption and hepatic glucose uptake elicited by luminal but not vascular glutamine in the jointly perfused small intestine and liver of the rat.
    Gardemann A, Watanabe Y, Grosse V, Hesse S, Jungermann K.
    Biochem J; 1992 May 01; 283 ( Pt 3)(Pt 3):759-65. PubMed ID: 1590766
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Decarboxylation of L-dopa and 5-hydroxytryptophan in dispersed rat pancreas acinar cells.
    Yu EW, Stern L, Tenenhouse A.
    Pharmacology; 1984 May 01; 29(4):185-92. PubMed ID: 6494232
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.